Cargando…
The prevalence of comorbidity in the lung cancer screening population: A systematic review and meta-analysis
OBJECTIVE: Comorbidity is associated with adverse outcomes for all lung cancer patients, but its burden is less understood in the context of screening. This review synthesises the prevalence of comorbidities among lung cancer screening (LCS) candidates and summarises the clinical recommendations for...
Autores principales: | Almatrafi, Anas, Thomas, Owen, Callister, Matthew, Gabe, Rhian, Beeken, Rebecca J, Neal, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925896/ https://www.ncbi.nlm.nih.gov/pubmed/35942779 http://dx.doi.org/10.1177/09691413221117685 |
Ejemplares similares
-
The radiology quality assurance process in the Yorkshire Lung Screening Trial, and findings from the baseline round of low dose CT screening for lung cancer
por: Upperton, Sara E C, et al.
Publicado: (2023) -
Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial
por: Crosbie, Philip A.J., et al.
Publicado: (2022) -
Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk
por: Crosbie, Philip AJ, et al.
Publicado: (2020) -
Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD
por: Bradley, Claire, et al.
Publicado: (2023) -
Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial
por: Upperton, Sara, et al.
Publicado: (2023)